Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (171-180 of 333) with videos related to

Pageof 34
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 updateC Bokemeyer, M S Aapro, A Courdi, et al.
Der Urologe. Ausg. A|October 31, 2018
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations]P Schriefer, M Hartmann, K Oechsle, et al.
Annals of Hematology|June 1, 1996
Acquired C 1-inhibitor deficiency with angioedema due to pleomorphic immunocytoma in a patient with three malignant tumors: long-term follow-up data and presentation of an additional caseW Bohle, U Rüther, C Bokemeyer, et al.
Der Urologe. Ausg. A|March 1, 1995
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]M A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomyM A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancerC Bokemeyer, M S Aapro, A Courdi, et al.
Seminars in Oncology|January 14, 1998
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancerC Bokemeyer, J T Hartmann, C S Lampe, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
British Journal of Cancer|October 29, 2002
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancerC Bokemeyer, K Oechsle, J T Hartmann, et al.
Pageof 34

Showing results (171-180 of 333) with videos related to

Sort By:
Pageof 34
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 updateC Bokemeyer, M S Aapro, A Courdi, et al.
Der Urologe. Ausg. A|October 31, 2018
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations]P Schriefer, M Hartmann, K Oechsle, et al.
Annals of Hematology|June 1, 1996
Acquired C 1-inhibitor deficiency with angioedema due to pleomorphic immunocytoma in a patient with three malignant tumors: long-term follow-up data and presentation of an additional caseW Bohle, U Rüther, C Bokemeyer, et al.
Der Urologe. Ausg. A|March 1, 1995
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]M A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomyM A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancerC Bokemeyer, M S Aapro, A Courdi, et al.
Seminars in Oncology|January 14, 1998
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancerC Bokemeyer, J T Hartmann, C S Lampe, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
British Journal of Cancer|October 29, 2002
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancerC Bokemeyer, K Oechsle, J T Hartmann, et al.
Pageof 34